comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 01:41:22 - browse：5

Illustration of puzzle pieces with doctors on them. One puzzle piece is missing in the middle. -- first opinion coverage from STAT — Adobe

The U.S. is running low on primary care physicians, with an estimated shortage of between 17,800 and 48,000 predicted by 2034. The dearth of doctors in this area has broad ramifications, ranging from more patients seeking care from specialty and emergency medicine to increased costs to the health care system and poorer public health outcomes.

One of the challenges to growing the ranks of primary care doctors is that family physicians and others in primary care typically have a much lower income than specialized doctors, as highlighted by a recent working paper from the Becker Friedman Institute for Economics at the University of Chicago.

Looking at tax data for nearly a million doctors over 13 years, the paper’s authors found that the average doctor in the U.S. earns $350,000 annually. Pay can climb much higher than that, with doctors between the ages of 40 and 55 who are in the top 10% of earners making an average $1.3 million per year. By comparison, primary care physicians in that age range, at their peak earning potential, earn an average $201,000 per year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： How to make the FDA’s new prescription one

WSS

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Will the IRA bring competition to the biologics market?

White House touts steps to stem shortages of cancer treatments

Virtual repurposing can help discover new uses for existing drugs

How housing is health care on Long Island

Medicare isn't yet testing food as medicine

leisure time

comprehensive

focus

The cancer drug shortage isn’t new — and neither are the solutions

Medicare isn't yet testing food as medicine

How to save PrEP access — and even expand it

Pfizer is about to make a big push in cancer. Will investors listen?

In Memoriam: Notable people who died in 2023

Study fuels hope CAR

Wildfire smoke exposes gaps in outdoor worker protections

Elisabeth Bik tackles the widespread issue of research misconduct

BioMarin wins approval for gene therapy to treat hemophilia A

WATCH: Why do bright lights make us see spots?

hotspot

Acelyrin, a rare IPO success, stumbles in its first big test

Telehealth for opioid use disorder is lifesaving

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Virtual repurposing can help discover new uses for existing drugs

Using force crossed my mind when examining a defiant young patient

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

hotspot

leisure time

entertainment

entertainment